Paul Tudor Jones Acadia Pharmaceuticals Inc Transaction History

Tudor Investment Corp Et Al

$25.1 Billion
Q4 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 71,680 shares of ACAD stock, worth $1.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

71,680

Previous 93,404 23.26%

Holding current value

$1.43 Million

Previous $1.44 Million 8.49%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $310,435 - $407,542	-21,724 Reduced 23.26%	71,680 $1.32 Million
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $129,719 - $163,991	-8,568 Reduced 8.4%	93,404 $1.44 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $387,196 - $487,835	26,484 Added 35.08%	101,972 $1.66 Million
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $1.34 Million - $2.33 Million	75,488 New	75,488 $1.4 Million
Q3 2023 Nov 15, 2023	BUY	$20.84 - $33.47 $1.7 Million - $2.73 Million	81,503 New	81,503 $1.7 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $1.1 Million - $2.31 Million	84,833 New	84,833 $1.2 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $964,559 - $1.27 Million	-46,063 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $395,908 - $638,782	23,580 Added 104.88%	46,063 $1.08 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $354,781 - $556,903	22,483 New	22,483 $373,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $633,119 - $894,851	-32,635 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $709,567 - $1.56 Million	28,360 Added 663.39%	32,635 $842,000
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $175,446 - $242,777	4,275 New	4,275 $229,000
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $155,294 - $243,048	-4,264 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $167,404 - $224,840	4,264 New	4,264 $207,000
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $1.42 Million - $2.1 Million	-44,793 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $3.28 Million - $4.66 Million	-90,572 Reduced 66.91%	44,793 $1.92 Million
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $3.01 Million - $5.96 Million	135,365 New	135,365 $4.87 Million
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $1.02 Million - $1.73 Million	-63,082 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $903,334 - $1.45 Million	63,082 New	63,082 $1.02 Million
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $1.14 Million - $1.91 Million	-87,705 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $1.32 Million - $1.96 Million	87,705 New	87,705 $1.34 Million
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $1.17 Million - $1.68 Million	-51,869 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $1.39 Million - $2.03 Million	51,869	51,869 $1.56 Million

Others Institutions Holding ACAD

# of Institutions

316

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.23B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account